Target intelligence / Profile preview

Type I Nitroreductase (NTR I)

Target
NTR I
Molecular classification
Enzyme, Oxidoreductase, Flavoenzyme
01

Overview

Type I nitroreductases are oxygen-insensitive flavoenzymes that catalyze the two-electron reduction of nitroaromatic compounds and quinones, utilizing NADH or NADPH as electron donors. They are found in bacteria and some eukaryotes, including protozoan parasites. They play a role in xenobiotic detoxification, prodrug activation (e.g., in antiparasitic therapy), and are exploited in gene-directed enzyme prodrug therapy (GDEPT) for cancer treatment. Unlike Type II nitroreductases, they do not generate reactive oxygen species.

Other names
Oxygen-insensitive nitroreductaseNTR type I
02

Mechanism of action

Reduction of nitroaromatic compounds and quinones, activating prodrugs or detoxifying xenobiotics.

03

Biological functions

DetoxificationProdrug activationRedox balanceUbiquinone reduction (in some organisms)
04

Disease associations

Infection (drug resistance/sensitivity in bacteria and protozoa)Cancer (GDEPT)
05

Safety considerations

Potential for off-target effects in GDEPTDevelopment of resistance in bacteria and protozoa
06

Interacting drugs

Nitrofurans

3 more in the full profile.

Beyond the preview

Go deeper on Type I Nitroreductase (NTR I).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Type I Nitroreductase (NTR I).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call